Dr. Areeba Patel is a postdoctoral researcher at the German Cancer Research Center (DKFZ) affiliated to the departments of Paediatric Neurooncology, Neuropathology and AI in Oncology. Currently, she leads tech R&D at Heidelberg Epignostix as the Head of New Technologies. Areeba has a background in engineering and completed her masters in Cancer Biology at Imperial College London. She completed her PhD in computational neuropathology in the lab of Felix Sahm at the DKFZ. Her research revolves around developing novel solutions using emerging technologies like Nanopore sequencing and AI-based computational histopathology to make precision CNS tumour diagnostics swift, accessible and affordable. She has developed MNP-Flex- a platform agnostic methylation classifier and Rapid-CNS2- a pipeline that enables rapid intraoperative molecular classification followed by comprehensive molecular profiling within the same day.